Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gaki Nima (Delhi, India), Gaki Nima, Balakrishnan Menon, Santosh Jha. Evaluation of vitamin D in asthma: Its effect on inflammatory markers and clinical profile. Eur Respir J 2015; 46: Suppl. 59, 3959

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of vitamin D in bronchial asthma and its correlation with lung function Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Effect of vitamin d therapy on the pulmonary functions in pediatric asthma and allergic rhinitis Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Evaluation of vitamin D in bronchial asthma and the effect of vitamin D supplementation on asthma severity and control: A randomised control trial Source: International Congress 2014 – Asthma: clinical problems Year: 2014 The effect of vitamin D therapy on airway reactivity and airway inflammation in asthmatic children Source: Annual Congress 2013 –Preschool wheeze Year: 2013 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Low vitamin D level and adult-onset bronchial asthma: Is there a link? Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Peripheral pathological ILC2: An inflammatory indicator for the assessment of asthma control in clinics Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Chronic rhinosinusitis with and without nasal polyps and rhinitis in adult asthma. Frequency distribution and relationship with asthma control and severity (the IRIS-ASMA study) Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Phenotypic characteristics of asthma with small airways involvement Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Clinical phenotypes in asthmatic population with severe asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3 Source: International Congress 2016 – Phenotyping asthma Year: 2016 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013